Exhibit 10.35

 

CERTAIN MATERIAL (INDICATED BY THREE ASTERISKS) HAS BEEN OMITTED FROM THIS
DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT.  THE OMITTED MATERIAL
HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

 

AMENDMENT TO SALES REPRESENTATIVE AGREEMENT

 

This Amendment to Sales Representative Agreement (the “Amendment”) is made and
entered into effective as of March 1, 2002 by and between OrthoLogic Corp., a
Delaware corporation, with its principal place of business at 1275 West
Washington Street, Tempe, AZ 85281 (“OrthoLogic”), and DePuy AcroMed, Inc., an
Ohio corporation, with its principal place of business at 325 Paramount Drive,
Raynham, MA 02767 (“DePuy AcroMed”).

 

RECITALS

 

A.                             OrthoLogic and DePuy AcroMed are parties to a
Sales Representative Agreement, dated August 18, 2000, as amended as of
August 1, 2001, (the “Agreement”), under which OrthoLogic appointed DePuy
AcroMed as its exclusive sales representative to sell OrthoLogic’s SpinaLogic
bone growth stimulation products, as set forth in Section 1.8 of the Agreement.

 

B.                             The parties now wish to add a new Section 12.2.1
to the Agreement.

 

AGREEMENTS

 

In consideration of the following mutual covenants, the adequacy and sufficiency
of which are hereby acknowledged, the parties hereby agree as follows:

 

1.                                       A new Section 12.2.1 is hereby added,
to read, as follows:

 

“Notwithstanding Section 12.2, effective March 1, 2002, OrthoLogic shall pay
DePuy AcroMed commissions of ***% of the Net Sales Price for all Product sales
made ***. At any time, either party may discontinue the *** upon 60 days’ prior
written notice to the other party. Upon discontinuation of the ***, the
commission rate to be paid by OrthoLogic to DePuy AcroMed will be governed by
Section 12.2 and this Section 12.2.1 shall no longer have any force or effect.

 

2.                                       Except as amended hereby, all
provisions and terms of the Agreement shall remain in force and unchanged.

 

 

ORTHOLOGIC CORP.

DEPUY ACROMED, INC.

 

 

Name:

/s/ Thomas Trotter

 

Name:

   (signature illegible)

 

 

 

 

 

 

 

Title:

President / CEO

 

Title:

   VP SALES

 

 

 

 

 

 

 

Date:

3/29/02

 

Date:

   3/28/02

 

 

--------------------------------------------------------------------------------

***Certain information on this page has been filed separately with the
Securities and Exchange Commission.  Confidential treatment has been requested
with respect to the omitted portions.

 

--------------------------------------------------------------------------------